RECALLS AND SAFETY ALERTS POTENTIALLY FATAL ERRORS WITH CERTAIN GLUCOSE TEST STRIPS
October 6, 2009
FDA is warning again that potentially fatal glucose monitoring errors can occur in patients who receive therapeutic products containing certain sugars other than glucose. These products include oral xylose, intravenous infusions that contain maltose ...
Additional Legal Resources: